27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Analyst Stock Ratings Upgrades

Analyst upgrades are typically bullish for a stock. When there is a stock upgrade, the analysts who rate the stock feel better about the company's future and typically either recommend someone holds or buys the stock. Updated 05/14/2024

No data available to display
date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert

Recent Analyst Stock Rating Upgrade News

TD Cowen Upgrades TKO Group Holdings to Buy, Announces $127 Price Target
TD Cowen analyst Stephen Gagola upgrades TKO Group Holdings (NYSE:TKO) from Hold to Buy and announces $127 price target.
TD Cowen Upgrades Janus Henderson Group to Buy, Announces $37 Price Target
TD Cowen analyst Janus Henderson upgrades Janus Henderson Group (NYSE:JHG) from Hold to Buy and announces $37 price target.
Bernstein Upgrades General Mills to Market Perform, Raises Price Target to $70
Bernstein analyst Alexia Howard upgrades General Mills (NYSE:GIS) from Underperform to Market Perform and raises the price target from $62 to $70.
Bernstein Upgrades Campbell Soup to Market Perform, Raises Price Target to $46
Bernstein analyst Alexia Howard upgrades Campbell Soup (NYSE:CPB) from Underperform to Market Perform and raises the price target from $42 to $46.
Brookline Capital Upgrades Dare Bioscience to Buy, Announces $3 Price Target
Brookline Capital analyst Kemp Dolliver upgrades Dare Bioscience (NASDAQ:DARE) from Hold to Buy and announces $3 price target.
Boston Beer Company Gets A Spicy Buy Upgrade From Analyst Amid Other Beer Brands - Read Why
Analyst upgrades Boston Beer Company to Buy, highlighting growth potential amid declining beer brands, while maintaining ratings for Constellation Brands and Molson Coors.
Leerink Partners Upgrades Enhabit to Market Perform, Announces $8.5 Price Target
Leerink Partners analyst Whit Mayo upgrades Enhabit (NYSE:EHAB) from Underperform to Market Perform and announces $8.5 price target.
Ligand Moves to Strong Buy: Rationale Behind the Upgrade
Investors might want to bet on Ligand Pharmaceuticals (NASDAQ: LGND), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Deutsche Bank Upgrades Edwards Lifesciences to Buy, Raises Price Target to $103
Deutsche Bank analyst Pito Chickering upgrades Edwards Lifesciences (NYSE:EW) from Hold to Buy and raises the price target from $86 to $103.
William Blair Upgrades Neuronetics to Outperform
William Blair analyst Margaret Kaczor upgrades Neuronetics (NASDAQ:STIM) from Market Perform to Outperform.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free